Prostate Cancer
Conditions
Interventions
Gold Standard:Pathological results, Gleason Grading
Index test:To explore the method of prostate biopsy guided by cross-modal artificial intelligence image elastic registration and fusion based on prostate multi-parametric magnetic resonance imaging an
Sponsors
Renmin Hospital of Wuhan University Hubei General Hospital
Eligibility
Sex/Gender
Male
Age
No minimum to 80 Years
Inclusion criteria
Inclusion criteria: 1. Male, under the age of 80; 2. Meet any of the following criteria: (1) Digital rectal examination (DRE) revealed suspicious nodules in the prostate, with any PSA values; (2) PSA >= 10 µg/L; (3) 4 µg/L = 3; 4. Good compliance, able to communicate well with researchers; 5. Volunteer to participate in the research and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Confirmed prostate cancer or acute prostatitis patients; 2. During the acute infection period, or clinical significance urinary tract infections; 3. Prostate biopsy performed within one month; 4. In the period of decompensation due to cardiac insufficiency; 5. Individuals with severe bleeding tendencies, or those who are unable to stop taking anticoagulants for a long time; 6. Severe internal hemorrhoids, external hemorrhoids, perianal or rectal lesions; 7. Patients with severe bone and joint diseases who cannot undergo lithotomy; 8. Having a hypertensive crisis; 9. Individuals who are unable to undergo anesthesia; 10. Those who suffer from mental illness or mental disorders and are unable to understand the informed consent form; 11. People who use electronic instruments such as built-in pacemakers, cochlear implants, and nerve stimulators; 12. Other contraindications to surgery, or those deemed unsuitable by the researcher to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of cs-PCa; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of any-PCa;Registration and fusion completion time (from magnetic resonance data import to MR-TRUS image fusion completion);Biopsy completion time (the time from the first needle to the last needle completed);Visual Analogue Scale; | — |
Countries
China
Contacts
Public ContactFan Cheng
Renmin Hospital of Wuhan University Hubei General Hospital
Outcome results
None listed